Bank of America's Ownership in Aptevo Therapeutics Inc.

The SEC filing reports that Bank of America Corporation, along with its subsidiaries Bank of America N.A. and BofA Securities, Inc., collectively own 27 shares of common stock in Aptevo Therapeutics Inc. The ownership is reported as indirect, and the shares are held through short-term stock borrowings. The filing includes footnotes clarifying that the reporting entities may be deemed to have temporarily held voting and dispositive power over additional shares due to these borrowings. The filing also states that the reporting entities are not acting as a group or in a syndicate for the purpose of acquiring, holding, or disposing of securities of Aptevo Therapeutics Inc. The period of report is September 30, 2025, and the filing is signed by Andres Ortiz as the authorized signatory for all three entities.